Tower Research Capital (TRC)’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.77K | Buy |
+9,285
| New | +$4.77K | ﹤0.01% | 4270 |
|
2024
Q4 | – | Sell |
-1,721
| Closed | -$3.72K | – | 5943 |
|
2024
Q3 | $3.72K | Sell |
1,721
-12,716
| -88% | -$27.5K | ﹤0.01% | 4788 |
|
2024
Q2 | $54.9K | Buy |
14,437
+13,198
| +1,065% | +$50.2K | ﹤0.01% | 3030 |
|
2024
Q1 | $3.85K | Sell |
1,239
-1,069
| -46% | -$3.32K | ﹤0.01% | 4780 |
|
2023
Q4 | $7.66K | Buy |
+2,308
| New | +$7.66K | ﹤0.01% | 4593 |
|
2023
Q3 | – | Sell |
-7,048
| Closed | -$29K | – | 6164 |
|
2023
Q2 | $29K | Buy |
7,048
+3,211
| +84% | +$13.2K | ﹤0.01% | 3028 |
|
2023
Q1 | $20K | Buy |
3,837
+1,330
| +53% | +$6.93K | ﹤0.01% | 3440 |
|
2022
Q4 | $15K | Buy |
2,507
+1,129
| +82% | +$6.76K | ﹤0.01% | 3446 |
|
2022
Q3 | $13K | Sell |
1,378
-205
| -13% | -$1.93K | ﹤0.01% | 4285 |
|
2022
Q2 | $16K | Buy |
1,583
+1,045
| +194% | +$10.6K | ﹤0.01% | 4021 |
|
2022
Q1 | $7K | Sell |
538
-2,108
| -80% | -$27.4K | ﹤0.01% | 4753 |
|
2021
Q4 | $43K | Buy |
+2,646
| New | +$43K | ﹤0.01% | 2887 |
|